
AstraZeneca is looking to harness the power of a pioneering genome-editing tool in a series of new collaborations. The UK …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

